Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?-Reference-Cited by-同舟云学术

Cancer-associated thrombosis: How many patients seen in clinical practice would be eligible for a direct oral anticoagulant randomized controlled trial?

Published:2024-06 Issue: Volume:85 Page:101069
ISSN:2590-0412
Container-title:Respiratory Medicine and Research
language:en
Short-container-title:Respiratory Medicine and Research

Author:

Petit Bastien,Soudet Simon,Poenou Géraldine^ORCID,Zarrat Emma,Accassat Sandrine,Plaisance Ludovic,Helfer Hélène,Mismetti Valentine,Hello Claire Le,Sevestre Marie-Antoinette,Mahé Isabelle,Bertoletti Laurent^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference38 articles.

1. Epidemiology of first and recurrent venous thromboembolism in patients with active cancer;Cohen;Thromb Haemost,2017

2. Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment;Abdol Razak;Cancers,2018

3. Epidemiology of cancer-associated venous thrombosis;Timp;Blood,2013

4. Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update 2014;Lyman;J Clin Oncol Off J Am Soc Clin Oncol,2015

5. Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis;Giustozzi;Thromb Haemost,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do all patients with cancer thrombosis have the same risk of bleeding and recurrence? Particularities of lung cancer;Expert Review of Respiratory Medicine;2024-02